Note: Ingredients listed on restricted chemical lists
EC/CAS
215-137-3/1305-62-0
Name of the chemical
Calcium dihydroxide
Concentration
>=10.0-<20.0%
EC/CAS
231-955-3/7782-42-5
Name of the chemical
Graphite
Concentration
>=20.0-<30.0%
General Information
Version
4.0
Revision date
2022-07-11
Product name
MOLYKOTE P-37 Antiseize Paste
1.2.1 Relevant identified uses
Lubricants and lubricant additives
Manufacturer Name
DuPont Specialty Products GmbH & Co. KG
Emergency telephone
+(44)-870-8200418
Icons in SDS
Company Information
company name
DuPont Specialty Products GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion-EU@dupont.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H315+P338+P302+P352, H318
Hazard statements
Code
Statements
H318
Causes serious eye damage.
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
DANGER
Hazard statements
H315 Causes skin irritation. H318 Causes serious eye damage.
Precautionary statements
P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, + P338 + if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ P310 doctor. P332 + P313 If skin irritation occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse. Supplemental informationThe following percentage of the mixture consists of ingredient(s) with unknown acute dermal toxicity: 29 %
Contains
Calcium hydroxide
2.3 Other hazards
Endocrine disrupting properties (human health): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Endocrine disrupting properties (environment): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008: Skin irritation - Category 2 - H315 Serious eye damage - Category 1 - H318 ® ™ Trademark of affiliates of DuPont de Nemours, Inc. For the full text of the H-Statements mentioned in this Section, see Section 16.